Gene signature in sessile serrated polyps identifies colon cancer subtype

Cancer Prevention Research

Volumn 9, Issue 6, 2016, Pages 456-465

  Kanth, Priyanka ^a   Bronner, Mary P ^b,c   Boucher, Kenneth M ^a,c   Burt, Randall W ^a,c   Neklason, Deborah W ^a   Hagedorn, Curt H ^a,d   Delker, Don A ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE 1 FAMILY MEMBER L1; ANNEXIN A10; B RAF KINASE; BETA CRYSTALLIN A2; CLAUDIN 1; FASCIN ACTIN BINDING PROTEIN 1; FOS LIKE ANTIGEN 1; KALLIKREIN RELATED PEPTIDASE 10; MUCIN 17; MUCIN 6; PROTEIN; PROTEIN MLH1; RNA; SEMENOGELIN; TMF1 REGULATED NUCLEAR PROTEIN 1; UNCLASSIFIED DRUG; VANIN 1; VESICULAR MONOAMINE TRANSPORTER 1; ZIC FAMILY MEMBER 2 PROTEIN; ZIC FAMILY MEMBER 5 PROTEIN; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; COLON CANCER; COLON POLYP; CONTROLLED STUDY; CPG ISLAND; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM ADENOMA; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; SESSILE SERRATED POLYP; TUMOR DIFFERENTIATION; ADOLESCENT; COLON TUMOR; FEMALE; GENETICS; MALE; POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COLONIC NEOPLASMS; COLONIC POLYPS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSCRIPTOME; YOUNG ADULT;

EID: 84973124505     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0363     Document Type: Article

References (53)

1. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. 2010. Available from: http://www.cdc.gov/.
2. Burgess NG, Pellise M, Nanda KS, Hourigan LF, Zanati SA, Brown GJ, et al. Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps. Gut 2016;65:437-46.
3. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343:162-8.
4. Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011;9:42-6.
5. Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumors of the digestive system. Lyon: IARC; 2010.
6. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003; 27:65-81.
7. Wong NA, Hunt LP, Novelli MR, Shepherd NA, Warren BF. Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology 2009;55:63-6.
8. Khalid O, Radaideh S, Cummings OW, O'Brien MJ, GoldblumJR, Rex DK. Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol 2009;15:3767-70.
9. Jasperson KW, Kanth P, Kirchhoff AC, Huismann D, Gammon A, Kohlmann W, et al. Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum 2013;56: 1211-6.
10. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000;119:323-32.
11. Boparai KS, Mathus-Vliegen EM, Koornstra JJ, Nagengast FM, van Leerdam M, van Noesel CJ, et al. Increased colorectal cancer risk during follow-up in patientswith hyperplastic polyposis syndrome: A multicentre cohort study. Gut 2010;59:1094-100.
12. Holme O, Bretthauer M, Eide TJ, Loberg EM, Grzyb K, Loberg M, et al. Longterm risk of colorectal cancer in individuals with serrated polyps. Gut 2015;64:929-36.
13. Makinen M.J. Colorectal serrated adenocarcinoma. Histopathology 2007; 50:131-50.
14. O'Brien MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 2007;36:947-68.
15. O'Brien MJ, Zhao Q, Yang S. Colorectal serrated pathway cancers and precursors. Histopathology 2015;66:49-65.
16. Iino H, Jass JR, Simms LA, Young J, Leggett B, Ajioka Y, et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: amild mutator pathway for colorectal cancer? J Clin Pathol 1999;52:5-9.
17. Guarinos C, Sánchez-Fortún C, Rodríguez-Soler M, Perez-Carbonell L, Egoavil C, Juarez M, et al. Clinical subtypes and molecular characteristics of serrated polyposis syndrome. Clin Gastroenterol Hepatol 2013;11:705-11.
18. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, et al. Evaluation of a large, population-based sample supports aCpG island methylator phenotype in colon cancer. Gastroenterology 2005;129: 837-45.
19. Gonzalo DH, Lai KK, Shadrach B, Goldblum JR, Bennett AE, Downs-Kelly E, et al. Gene expression profiling of serrated polyps identifies annexin A10 as amarker of a sessile serrated adenoma/polyp. J Pathol 2013;230:420-9.
20. Caruso M, Moore J, Goodall GJ, Thomas M, Phillis S, Tyskin A, et al. Overexpression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Arch 2009;454:291-302.
21. Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, et al. RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PLoS One 2014;9:e88367.
22. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR, et al. United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: A consensus update by theUS Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143:844-57.
23. Folkers ME, Delker DA, Maxwell CI, Nelson CA, Schwartz JJ, Nix DA, et al. ENCODE tiling array analysis identifies differentially expressed annotated and novel 50 capped RNAs in hepatitis C infected liver. PLoS One 2011;6: e14697.
24. Papic N, Maxwell CI, Delker DA, Liu S, Heale BS, Hagedorn CH. RNAsequencing analysis of 50 capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection. Viruses 2012;4: 581-612.
25. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol 2014;15:550.
26. Comprehensive molecular characterization of human colon and rectal cancer. Cancer Genome Atlas Network. Nature 2012;487:330-7.
27. National Institutes of Health. TCGA data portal. Available from: https://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp.
28. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer geno mics and clinical profiles using the cBioPortal. Sci Signali 2013;6:pl1.
29. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2:401-4.
30. Ciriello G, Cerami E, Sander C, Schultz N. Mutual exclusivity analysis identifies oncogenic network modules. Genome Res 2012;22:398-406.
31. Caruso M1, Fung KY2, Moore J3, Brierley GV, Cosgrove LJ, Thomas M, et al. Claudin-1 expression is elevated in colorectal cancer precursor lesions harboring the BRAF V600E. Transl Oncol 2014;7:456-63.
32. DiSario JA, Foutch PG, Mai HD, Pardy K, Manne RK. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 1991;86:941-5.
33. Weston AP, Campbell DR. Diminutive colonic polyps: histopathology, spatial distribution, concomitant significant lesions, and treatment complications. Am J Gastroenterol 1995;90:24-8.
34. Popovici V, Budinska E, Tejpar S, Weinrich S, Estrella H, Hodgson G, et al. Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J Clin Oncol 2012;30:1288-95.
35. Guinney J, Dienstmann R, Wang X, De Reynies A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med 2015;21:1350-6.
36. De Sousa EMelo F, Wang X, Jansen M, Fessler E, Trinh A, De Rooij LP, et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med 2013;19:614-8.
37. Merzdorf CS. Emerging roles for zic genes in early development. Dev Dyn 2007;236:922-40.
38. Sanek NA, Taylor AA, Nyholm MK, Grinblat Y. Zebrafish zic2a patterns the forebrain through modulation of Hedgehog-activated gene expression. Development 2009;136:3791-800.
39. Marchini S, Poynor E, Barakat RR, Clivio L, Cinquini M, Fruscio R, et al. The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer. Clin Cancer Res 2012;18:4313-24.
40. Chan DW, Liu VW, Leung LY, Yao KM, Chan KK, Cheung AN, et al. Zic2 synergistically enhances Hedgehog signalling through nuclear retention of Gli1 in cervical cancer cells. J Pathol 2011;225:525-34.
41. Ma Y, Machesky LM. Fascin1 in carcinomas: Its regulation and prognostic value. Int J Cancer 2015;137:2534-44.
42. Conesa-Zamora P, García-Solano J, García-García F, Turpin Mdel C, Trujillo- Santos J, Torres-Moreno D, et al. Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. Int J Cancer 2013;132:297-307.
43. Stahl R, Walcher T, De Juan Romero C, Pilz GA, Cappello S, Irmler M, et al. Trnp1 regulates expansion and folding of the mammalian cerebral cortex by control of radial glial fate. Cell 2013;153:535-49.
44. Owens SR, Chiosea SI, Kuan SF. Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol 2008;21:660-9.
45. Walsh MD, Clendenning M, Williamson E, Pearson SA, Walters RJ, Nagler B, et al. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol 2013;26:1642-56.
46. Neuhaus J, Schiffer E, von Wilcke P, BauerHW, Leung H, SiwyJ, et al. Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease. PLoS One 2013;8:e67514.
47. Abe M, Watanabe N, McDonell N, Takato T, Ohira M, Nakagawara A, et al. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology 2008;74:50-60.
48. Hawthorn L, Lan L, Mojica W. Evidence for field effect cancerization in colorectal cancer. Genomics 2014;103:211-21.
49. Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, Giovannucci E, et al. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol 2015;28:14-29.
50. Chen LC, Hao CY, Chiu YS, Wong P, Melnick JS, Brotman M, et al. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res 2004;64:3694-700.
51. Huang CS, Farraye FA, Yang S, O'Brien MJ. The clinical significance of serrated polyps. Am J Gastroenterol 2011;106:229-40.
52. Donehower LA, Creighton CJ, Schultz N, Shinbrot E, Chang K, Gunaratne PH, et al. MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. J Pathol 2013;229:99-110.
53. Burnett-Hartman AN, Newcomb PA, Potter JD, Passarelli MN, Phipps AI, Wurscher MA, et al. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res 2013; 73:2863-72.